Combining Antiviral Pills With Experimental Drug Brequinar Effective in Treating COVID: Study

A COVID-19 treatment pill, called molnupiravir, developed by Merck & Co Inc. and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc., on Oct. 26, 2021. Merck & Co Inc./Reuters

Researchers have found that combining the antivirals remdesivir or molnupiravir with the experimental drug brequinar could be effective in treating the Chinese Communist Party (CCP) virus, which causes COVID-19.

The new drug combination was discovered by researchers at the University of Maryland School of Medicine (UMSOM) and the University of Pennsylvania Perelman School of Medicine.